risk of SZ
early detection of SZ
relative prevalence of SZ
diagnostic tools
Early Molecular Diagnostics of Schizophrenia Schizophrenia
development of molecular diagnostics tools
molecular psychiatry
development of new diagnostic possibilities
limited diagnostic arsenal
TEST training network
management costs
health care costs
considerable socioeconomic burden
high degree of patient disability
leading cause of disease burden
unbiased high-throughput omic screens
exposure
immune system status
pathogens
specific lifestyle choices
unique animal
biotech R
cell models
relevant cohorts of human subjects
knowledge-based candidate marker analyses
neurodevelopmental defects
epigenetics
clinical immunology
Finland
mechanisms
complementary areas of expertise
genetic vulnerabilities
regions
northern Sweden
globe
better understanding
challenges
times corresponding national
quality of life
overarching hypothesis
chronic nature
systematic multivariate analysis
total healthcare budget
Western countries
regional averages
efforts
factors
understood aetiology
devastating illnesses
critical need
severe mental disorder
major impact
Europe
efficient manner
situation
onset of psychosis
adult population